A detailed history of Millburn Ridgefield Corp transactions in Zoetis Inc. stock. As of the latest transaction made, Millburn Ridgefield Corp holds 81 shares of ZTS stock, worth $13,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Previous 84 3.57%
Holding current value
$13,340
Previous $14,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$172.58 - $196.48 $517 - $589
-3 Reduced 3.57%
81 $15,000
Q2 2024

Aug 14, 2024

SELL
$145.54 - $178.83 $1,455 - $1,788
-10 Reduced 10.64%
84 $14,000
Q1 2024

Apr 26, 2024

SELL
$165.67 - $199.94 $331 - $399
-2 Reduced 2.08%
94 $15,000
Q4 2023

Feb 06, 2024

SELL
$151.44 - $200.09 $908 - $1,200
-6 Reduced 5.88%
96 $18,000
Q3 2023

Nov 02, 2023

BUY
$167.14 - $192.77 $17,048 - $19,662
102 New
102 $17,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Millburn Ridgefield Corp Portfolio

Follow Millburn Ridgefield Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millburn Ridgefield Corp, based on Form 13F filings with the SEC.

News

Stay updated on Millburn Ridgefield Corp with notifications on news.